🎉 M&A multiples are live!
Check it out!

XOMA Royalty Valuation Multiples

Discover revenue and EBITDA valuation multiples for XOMA Royalty and similar public comparables like Galapagos, Benevolent AI, and Julphar.

XOMA Royalty Overview

About XOMA Royalty

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.


Founded

1981

HQ

United States of America
Employees

13

Website

xoma.com

Financials

LTM Revenue $29.5M

LTM EBITDA -$12.6M

EV

$257M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

XOMA Royalty Financials

XOMA Royalty has a last 12-month revenue of $29.5M and a last 12-month EBITDA of -$12.6M.

In the most recent fiscal year, XOMA Royalty achieved revenue of $10.2M and an EBITDA of -$5.4M.

XOMA Royalty expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See XOMA Royalty valuation multiples based on analyst estimates

XOMA Royalty P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $4.8M $10.2M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$39.4M -$5.4M XXX XXX XXX
EBITDA Margin -827% -53% XXX XXX XXX
Net Profit -$17.1M -$40.8M XXX XXX XXX
Net Margin -359% -400% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

XOMA Royalty Stock Performance

As of April 15, 2025, XOMA Royalty's stock price is $20.

XOMA Royalty has current market cap of $243M, and EV of $257M.

See XOMA Royalty trading valuation data

XOMA Royalty Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$257M $243M XXX XXX XXX XXX $-1.32

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

XOMA Royalty Valuation Multiples

As of April 15, 2025, XOMA Royalty has market cap of $243M and EV of $257M.

XOMA Royalty's trades at 8.7x LTM EV/Revenue multiple, and -20.4x LTM EBITDA.

Analysts estimate XOMA Royalty's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for XOMA Royalty and 10K+ public comps

XOMA Royalty Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $257M XXX XXX XXX
EV/Revenue 25.1x XXX XXX XXX
EV/EBITDA -47.4x XXX XXX XXX
P/E -17.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -18.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get XOMA Royalty Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

XOMA Royalty Valuation Multiples

XOMA Royalty's NTM/LTM revenue growth is 19%

XOMA Royalty's revenue per employee for the last fiscal year averaged $0.8M, while opex per employee averaged $1.5M for the same period.

Over next 12 months, XOMA Royalty's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate XOMA Royalty's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for XOMA Royalty and other 10K+ public comps

XOMA Royalty Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 115% XXX XXX XXX XXX
EBITDA Margin -53% XXX XXX XXX XXX
EBITDA Growth -86% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -34% XXX XXX XXX XXX
Revenue per Employee $0.8M XXX XXX XXX XXX
Opex per Employee $1.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 337% XXX XXX XXX XXX
R&D Expenses to Revenue 28% XXX XXX XXX XXX
Opex to Revenue 189% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

XOMA Royalty Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

XOMA Royalty M&A and Investment Activity

XOMA Royalty acquired  XXX companies to date.

Last acquisition by XOMA Royalty was  XXXXXXXX, XXXXX XXXXX XXXXXX . XOMA Royalty acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by XOMA Royalty

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About XOMA Royalty

When was XOMA Royalty founded? XOMA Royalty was founded in 1981.
Where is XOMA Royalty headquartered? XOMA Royalty is headquartered in United States of America.
How many employees does XOMA Royalty have? As of today, XOMA Royalty has 13 employees.
Who is the CEO of XOMA Royalty? XOMA Royalty's CEO is Mr. Owen P. Hughes, Jr.
Is XOMA Royalty publicy listed? Yes, XOMA Royalty is a public company listed on NAS.
What is the stock symbol of XOMA Royalty? XOMA Royalty trades under XOMA ticker.
When did XOMA Royalty go public? XOMA Royalty went public in 1986.
Who are competitors of XOMA Royalty? Similar companies to XOMA Royalty include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of XOMA Royalty? XOMA Royalty's current market cap is $243M
What is the current revenue of XOMA Royalty? XOMA Royalty's last 12-month revenue is $29.5M.
What is the current EBITDA of XOMA Royalty? XOMA Royalty's last 12-month EBITDA is -$12.6M.
What is the current EV/Revenue multiple of XOMA Royalty? Current revenue multiple of XOMA Royalty is 8.7x.
What is the current EV/EBITDA multiple of XOMA Royalty? Current EBITDA multiple of XOMA Royalty is -20.4x.
What is the current revenue growth of XOMA Royalty? XOMA Royalty revenue growth between 2023 and 2024 was 115%.
Is XOMA Royalty profitable? Yes, XOMA Royalty is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.